Dexide
Executive Summary
Mary Bruch is VP Regulatory Affairs & Life Sciences, not a consultant to the firm, as reported in the July 1 issue of "The Pink Sheet," T&G-3.
Mary Bruch is VP Regulatory Affairs & Life Sciences, not a
consultant to the firm, as reported in the July 1 issue of "The
Pink Sheet," T&G-3. |